GATA2将干性连接至急性髓系白血病的化疗耐药
研究揭示干细胞转录因子GATA2通过转录调控RASSF4(MDM2调节因子)抑制p53介导的凋亡,从而将干性与急性髓系白血病化疗耐药直接关联。GATA2高表达的小鼠AML对多柔比星更耐药,多柔比星与nutlin-3在GATA2高表达AML中具有协同作用。
要点
- GATA2表达在AML患者中具有显著的个体内和个体间差异,且随分子亚型变化。
- GATA2通过调控RASSF4(MDM2调节因子)抑制p53介导的凋亡,导致多柔比星耐药。
- 多柔比星与nutlin-3在Gata2高表达小鼠AML和AML患者样本中具有协同作用。
核心结论
- GATA2通过转录调控RASSF4(MDM2调节因子)抑制p53介导的凋亡,将干性相关转录因子表达与AML化疗耐药直接关联。
研究设计与样本
- 研究采用小鼠AML模型、患者样本、染色质免疫沉淀测序、RNA测序及功能研究。
主要发现
- 在源自干细胞或未成熟祖细胞群的KMT2A-MLL3驱动小鼠AML模型中,Gata2表达更高且对多柔比星更耐药。
- Gata2缺失导致多柔比星暴露后p53诱导更显著。
- GATA2调控RASSF4表达,且GATA2与RASSF4在人细胞系及AML患者 bulk 和单细胞表达数据集中呈负相关。
- 在Gata2低表达细胞中敲低Rassf4导致多柔比星或nutlin-3耐药;过表达Rassf4使Gata2高表达细胞敏感化。
- 多柔比星与nutlin-3在Gata2高表达小鼠AML和AML患者样本中具有协同作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Stemness-associated cell states are linked to chemotherapy resistance in acute myeloid leukemia (AML). We uncovered a direct mechanistic link between expression of the stem cell transcription factor GATA2 and drug resistance. The GATA-binding protein 2 (GATA2) plays a central role in blood stem cell generation and maintenance. We find substantial intrapatient and interpatient variability in GATA2 expression across samples from patients with AML. GATA2 expression varies by molecular subtype and has been linked to outcome. In a murine model, KMT2A-MLL3-driven AML originating from a stem cell or immature progenitor cell population has higher Gata2 expression and is more resistant to the standard AML chemotherapy agent doxorubicin. Deletion of Gata2 resulted in a more robust induction of p53 after exposure to doxorubicin. Chromatin immunoprecipitation sequencing, RNA sequencing, and functional studies revealed that GATA2 regulates the expression of RASSF4, a modulator of the p53 inhibitor MDM2 (mouse double minute 2). GATA2 and RASSF4 are anticorrelated in human cell lines and in bulk and single-cell expression data sets from patients with AML. Knockdown of Rassf4 in Gata2-low cells resulted in doxorubicin or nutlin-3 resistance. Conversely, overexpression of Rassf4 results in sensitization of cells expressing high levels of Gata2. Finally, doxorubicin and nutlin-3 are synergistic in Gata2-high murine AML and in samples from patients with AML. We discovered a previously unappreciated role for GATA2 in dampening p53-mediated apoptosis via transcriptional regulation of RASSF4, a modulator of MDM2. This role for GATA2 directly links the expression of a stemness-associated transcription factor to chemotherapy resistance.
引用
- Alikarami F, Xie HM, Riedel SS, et al. GATA2 links stemness to chemotherapy resistance in acute myeloid leukemia. Blood. 2025. PMID: 39841459. doi:10.1182/blood.2024025761
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。